Report Overview
www.reallygreatsite.com
Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring anatomic structure, such as the nasal cavity. Alternatively, the oral cancers may originate in any of the tissues of the mouth, and may be of varied histologic types: teratoma, adenocarcinoma derived from a major or minor salivary gland, lymphoma from tonsillar or other lymphoid tissue, or melanoma from the pigment-producing cells of the oral mucosa.
Market Share
The Global Oral Cancer Treatment Market Size was estimated at USD 2552.37 million in 2023 and is projected to reach USD 3229.57 million by 2029, exhibiting a CAGR of 4.00% during the forecast period.
The USA market for Global Oral Cancer Treatment Market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Key Company
•Bristol-Myers Squibb
•Qilu Pharmaceutical
•Teva Pharmaceutical Industries
•Eli Lilly And Company
•Roche
•Merck
•Novartis
•Pfizer
Market Segmentation
• Squamous Cell Carcinoma
• Verrucous Carcinoma
• Minor Salivary Gland Carcinomas
• Lymphomas
By Application
• Hospitals & Clinics
• Research Organization
• Academic Institutes
Geographic Segmentation
•North America: USA, Canada, Mexico
•Europe: Germany, UK, France, Russia, Italy, Rest of Europe
•Asia-Pacific: China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific
•South America: Brazil, Argentina, Colombia, Rest of South America
•Middle East and Africa: Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA
